Loss of ubiquitin E2 Ube2w rescues hypersensitivity of Rnf4 mutant cells to DNA damage

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Maure, Jean François ^a   Moser, Sandra C ^a   Jaffray, Ellis G ^a   Alpi, Arno F ^a   Hay, Ronald T ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR PROTEIN; RNF4 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; UBE2W PROTEIN, HUMAN; UBIQUITIN CONJUGATING ENZYME;

ANIMAL; CELL CULTURE; CHICKEN; DEFICIENCY; DNA DAMAGE; HUMAN; METABOLISM;

ANIMALS; CELLS, CULTURED; CHICKENS; DNA DAMAGE; HUMANS; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; UBIQUITIN-CONJUGATING ENZYMES;

EID: 84969179626     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep26178     Document Type: Article

References (47)

1. Bohgaki, T., Bohgaki, M. & Hakem, R. DNA double-strand break signaling and human disorders. Genome Integr 1, 15 (2010).
2. Curtin, N. PARP inhibitors for anticancer therapy. Biochem Soc Trans 42, 82-8 (2014).
3. Huhn, D., Bolck, H. A. & Sartori, A. A. Targeting DNA double-strand break signalling and repair: recent advances in cancer therapy. Swiss Med Wkly 143, w13837 (2013).
4. Betermier, M., Bertrand, P. & Lopez, B. S. Is non-homologous end-joining really an inherently error-prone process? PLoS Genet 10, e1004086 (2014).
5. Patel, K. J. & Joenje, H. Fanconi anemia and DNA replication repair. DNA Repair (Amst) 6, 885-90 (2007).
6. Rogers C. M., v. K. K. & Bochman M. L. Helicases involved in the repair of DNA inter-strand crosslinks. OA Biology 22 (2014).
7. Brown, J. S. & Jackson, S. P. Ubiquitylation, neddylation and the DNA damage response. Open Biol 5, 150018 (2015).
8. Niedernhofer, L. J., Lalai, A. S. & Hoeijmakers, J. H. Fanconi anemia (cross)linked to DNA repair. Cell 123, 1191-8 (2005).
9. Kim, H. & D'Andrea, A. D. Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway. Genes Dev 26, 1393-408 (2012).
10. Lachaud, C. et al. Distinct functional roles for the two SLX4 ubiquitin-binding UBZ domains mutated in Fanconi anemia. J Cell Sci. 127, 2811-7 (2014).
11. Alpi, A. F., Pace, P. E., Babu, M. M. & Patel, K. J. Mechanistic insight into site-restricted monoubiquitination of FANCD2 by Ube2t, FANCL, and FANCI. Mol Cell 32, 767-77 (2008).
12. Liu, T., Ghosal, G., Yuan, J., Chen, J. & Huang, J. FAN1 acts with FANCI-FANCD2 to promote DNA interstrand cross-link repair. Science 329, 693-6 (2010).
13. Smogorzewska, A. et al. A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair. Mol Cell 39, 36-47 (2010).
14. Kratz, K. et al. Deficiency of FANCD2-associated nuclease KIAA1018/FAN1 sensitizes cells to interstrand crosslinking agents. Cell 142, 77-88 (2010).
15. MacKay, C. et al. Identification of KIAA1018/FAN1, a DNA repair nuclease recruited to DNA damage by monoubiquitinated FANCD2. Cell 142, 65-76 (2010).
16. Cremona, C. A. et al. Extensive DNA damage-induced sumoylation contributes to replication and repair and acts in addition to the mec1 checkpoint. Mol Cell 45, 422-32 (2012).
17. Galanty, Y. et al. Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks. Nature 462, 935-9 (2009).
18. Morris, J. R. et al. The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Nature 462, 886-90 (2009).
19. Jackson, S. P. & Durocher, D. Regulation of DNA damage responses by ubiquitin and SUMO. Mol Cell 49, 795-807 (2013).
20. Geoffroy, M. C. & Hay, R. T. An additional role for SUMO in ubiquitin-mediated proteolysis. Nat Rev Mol Cell Biol 10, 564-8 (2009).
21. Dunnebier, T. et al. Polymorphisms in the UBC9 and PIAS3 genes of the SUMO-conjugating system and breast cancer risk. Breast Cancer Res Treat 121, 185-94 (2009).
22. Kim, J. H. et al. Roles of sumoylation of a reptin chromatin-remodelling complex in cancer metastasis. Nat Cell Biol 8, 631-9 (2006).
23. Yang, X. J. & Chiang, C. M. Sumoylation in gene regulation, human disease, and therapeutic action. F1000Prime Rep. 5, 45 (2013).
24. Tatham, M. H. et al. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat Cell Biol 10, 538-46 (2008).
25. Yin, Y. et al. SUMO-targeted ubiquitin E3 ligase RNF4 is required for the response of human cells to DNA damage. Genes Dev 26, 1196-208 (2012).
26. Galanty, Y., Belotserkovskaya, R., Coates, J. & Jackson, S. P. RNF4, a SUMO-targeted ubiquitin E3 ligase, promotes DNA double-strand break repair. Genes Dev 26, 1179-95 (2012).
27. Tatham, M. H., Plechanovova, A., Jaffray, E. G., Salmen, H. & Hay, R. T. Ube2W conjugates ubiquitin to alpha-amino groups of protein N-termini. Biochem J 453, 137-45 (2013).
28. Scaglione, K. M. et al. The ubiquitin-conjugating enzyme (E2) Ube2w ubiquitinates the N terminus of substrates. J Biol Chem 288, 18784-8 (2013).
29. Fletcher, A. J. et al. TRIM5alpha requires Ube2W to anchor Lys63-linked ubiquitin chains and restrict reverse transcription. Embo J 34, 2078-95 (2015).
30. Xie, J. et al. RNF4-mediated polyubiquitination regulates the Fanconi anemia/BRCA pathway. J Clin Invest 125, 1523-32 (2015).
31. Gibbs-Seymour, I. et al. Ubiquitin-SUMO circuitry controls activated fanconi anemia ID complex dosage in response to DNA damage. Mol Cell 57, 150-64 (2015).
32. Machida, Y. J. et al. UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Mol Cell 23, 589-96 (2006).
33. Alpi, A. et al. UBE2T, the Fanconi anemia core complex, and FANCD2 are recruited independently to chromatin: a basis for the regulation of FANCD2 monoubiquitination. Mol Cell Biol 27, 8421-30 (2007).
34. Zhang, Y. et al. UBE2W interacts with FANCL and regulates the monoubiquitination of Fanconi anemia protein FANCD2. Mol Cells 31, 113-22 (2010).
35. Yin, G. et al. Cloning, characterization and subcellular localization of a gene encoding a human Ubiquitin-conjugating enzyme (E2) homologous to the Arabidopsis thaliana UBC-16 gene product. Front Biosci 11, 1500-7 (2006).
36. Wang, B. et al. Loss of the Ubiquitin-conjugating Enzyme Ube2W results in susceptibility to early postnatal lethality and defects in skin, immune and male reproductive systems. J Biol Chem 291, 3030-42 (2015).
37. Schmidt, C. K. et al. Systematic E2 screening reveals a UBE2D-RNF138-CtIP axis promoting DNA repair. Nat Cell Biol 17, 1458-70 (2016).
38. Christensen, D. E., Brzovic, P. S. & Klevit, R. E. E2-BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages. Nat Struct Mol Biol 14, 941-8 (2007).
39. Pace, P. et al. Ku70 corrupts DNA repair in the absence of the Fanconi anemia pathway. Science 329, 219-23 (2010).
40. Adamo, A. et al. Preventing nonhomologous end joining suppresses DNA repair defects of Fanconi anemia. Mol Cell 39, 25-35 (2010).
41. Wang, A. T. et al. A Dominant Mutation in Human RAD51 Reveals Its Function in DNA Interstrand Crosslink Repair Independent of Homologous Recombination. Mol Cell 59, 478-90 (2015).
42. Vittal, V. et al. Intrinsic disorder drives N-terminal ubiquitination by Ube2w. Nat Chem Biol 11, 83-9 (2015).
43. Qi, C. et al. Biochemical and structural characterization of a novel ubiquitin-conjugating enzyme E2 from Agrocybe aegeria reveals Ube2w family-specific properties. Sci. Rep. 5, 16056 (2015).
44. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-23 (2013).
45. Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823-6 (2013).
46. Niedzwiedz, W. et al. The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair. Mol Cell 15, 607-20 (2004).
47. Mosedale, G. et al. The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway. Nat Struct Mol Biol 12, 763-71 (2005).